In the BioHarmony Drug Report Database

"Preview" Icon

Enalapril

Epaned, Vasotec (enalapril) is a small molecule pharmaceutical. Enalapril was first approved as Epaned on 1985-12-24. It is used to treat bartter syndrome, diabetic nephropathies, edema, heart failure, and left ventricular dysfunction amongst others in the USA. The pharmaceutical is active against angiotensin-converting enzyme. Vasotec’s patents are valid until 2036-03-25 (FDA).

 

Trade Name

 

Epaned, Vasotec
 

Common Name

 

enalapril
 

ChEMBL ID

 

CHEMBL578
 

Indication

 

bartter syndrome, diabetic nephropathies, edema, heart failure, left ventricular dysfunction, malignant hypertension, rheumatoid arthritis
 

Drug Class

 

Narcotic agonists/antagonists (normorphine type); antihypertensives (ACE inhibitors)

Image (chem structure or protein)

Enalapril structure rendering